evidence-led peptide journalism. not medical advice.
reptides · 32 min read · part of lifetime access ($100 once)

the FDA dose protocol.

every approved peptide on reptides. the label dosing, titration ladders, side-effect record, and brand-equivalence rules in one reference..

own it forever · $100 →
already bought · sign in →

$100 once unlocks all paid features: every paid brief, Ask, the journal, and future paid updates, for life.

"the FDA prescribing PDFs run 47 pages each. the dose lives on page 28. we built the table."

what's inside
  • →every peptide on the site with a real FDA file. 13 molecules, every brand.
  • →label dosing, titration ladder, route, frequency, starting dose in one sortable table.
  • →side-effect frequencies pulled straight from the trial record.
  • →brand-equivalence rules for the GLP-1 class (Wegovy vs Ozempic vs Rybelsus, Mounjaro vs Zepbound).
  • →dose ceilings, missed-dose rules, escalation cadence, the point where the label says stop.
  • →every row cross-links to the FDA prescribing information so you verify against the source PDF in two clicks.

one read, ~30 minutes, all sourced to FDA prescribing information. one of many briefs included with $100 lifetime access.

free excerpt

this is the spreadsheet. 13 peptides on reptides have a real FDA file. some ship multiple brands at different labels (semaglutide as Wegovy, Ozempic, Rybelsus; tirzepatide as Mounjaro and Zepbound). some have one approval and one brand (Egrifta, Vyleesi, Scenesse, Forzinity). all of it lives above.

chapters · 8
  1. 01the index. every FDA-approved peptide, every brand, every dosethe reference table
  2. 02what an FDA-approved dose actually isframing
  3. 03the GLP-1 class. semaglutide, tirzepatide, liraglutideweight loss · type 2 diabetes
  4. 04the GH-axis. hgh, tesamorelin, sermorelingrowth hormone replacement · HIV-lipodystrophy · pediatric GHD
  5. 05the melanocortin family. pt-141, melanotan-i, oxytocinsexual function · pigmentation · perioperative
  6. 06fertility and hormonal. hcg, gonadorelin, triptorelinreproductive endocrinology · GnRH axis
  7. 07the rare-disease lane. ss-31 / elamipretidemitochondrial · Barth syndrome
  8. 08the brand-equivalence problemWegovy vs Ozempic, Mounjaro vs Zepbound
who this is for
you've been handed a prescription
and the leaflet runs 60 pages. you want the actual dose, the actual schedule, and the actual side-effect rate in one place.
you're in the clinic conversation
and you want to know what a real FDA-approved dose looks like before you accept what a compounder calls equivalent.
you track how a label reads
and you want each brand's missed-dose rule, re-escalation rule, and side-effect cadence in one view.
you write or trade in this space
and you want the regulatory floor, every brand-equivalence rule, and every fda-label dose for 13 peptides in one source.
one lifetime license · no renewal
$100.

one payment for every reptides editorial brief, every research tool, and every future paid release. yours forever.

own it forever · $100 →
one payment by Stripe · yours forever · research reference, not medical advice